XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows Used In Operating Activities    
Net loss before dividends declared and accretion of Series A preferred stock $ (54,305) $ (9,938)
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:    
Change in fair value of contingent consideration 747 6,878
Loss on discontinued operations 0 463
Gain from equity method investees (578) (2,548)
Depreciation and amortization expenses 61,409 30,218
Stock-based compensation expense 19,676 12,358
Deferred tax provision (benefit) (71,019) 472
Amortization of contract cost assets 5,672 13,186
Amortization of deferred financing costs 1,915 1,079
Right-of-use asset impairment 24,065 0
Change in tax receivable agreement liability 66,184 0
Right-of-use operating assets 1,147 (669)
Operating lease liabilities (338) 179
Other current operating cash outflows, net 20 692
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable, net and contract assets (63,137) 13,042
Prepaid expenses and other current and non-current assets (21,142) (8,453)
Contract cost assets (2,859) (3,284)
Accounts payable (12,732) (823)
Accrued liabilities 11,944 (24,826)
Accrued compensation and employee benefits (20,643) (22,379)
Deferred revenue 1,050 (3,233)
Reserve for claims and performance-based arrangements 46,081 (45,334)
Other long-term liabilities (477) (858)
Net cash and restricted cash used in operating activities (7,320) (43,778)
Cash Flows Provided by (Used In) Investing Activities    
Cash paid for asset acquisitions and business combinations (388,246) (9,070)
Proceeds from transfer of membership and release of Passport escrow 0 22,969
Return of equity method investments 799 4,175
Investments in internal-use software and purchases of property and equipment (15,900) (17,744)
Net cash and restricted cash provided by (used in) investing activities (403,347) 330
Cash Flows Provided by (Used In) Financing Activities    
Changes in working capital balances related to claims processing on behalf of partners 33,122 360
Proceeds from stock option exercises 4,654 309
Proceeds from issuance of long-term debt, net of offering costs 256,063 0
Repayment of long-term debt (37,500) 0
Distributions to Sponsors 0 (14,884)
Proceeds from issuance of preferred stock, net of offering costs 168,000 0
Payment of preferred dividends (8,535) 0
Taxes withheld and paid for vesting of equity awards (12,745) (16,471)
Net cash and restricted cash provided by (used in) financing activities 403,059 (30,686)
Effect of exchange rate on cash and cash equivalents and restricted cash 49 (375)
Net decrease in cash and cash equivalents and restricted cash (7,559) (74,509)
Cash and cash equivalents and restricted cash as of beginning-of-period 215,158 354,942
Cash and cash equivalents and restricted cash as of end-of-period $ 207,599 $ 280,433